Neuromuscular Block and Anesthetic Depth Monitoring

Cholecystectomy, Laparoscopic Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02575443
• Other study ID #: ADMS NMD depth
• Status: Completed
• Phase: N/A
• Start date: September 2015
• Est. completion date: September 2017

Study information

• Verified date: October 2018
• Source: Seoul National University Bundang Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluated whether the depth of neuromuscular block may affect the unicon value of anesthetic depth monitoring system (ADMS).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: September 2017
• Est. primary completion date: September 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 80 Years

Eligibility

Inclusion Criteria:

• Gall bladder disease

• American Society of Anesthesiologist physical status 1 or 2

Exclusion Criteria:

• Pregnancy

• Body mass index < 16

• Body mass index >30

• Neuromuscular disease

• Previous intraabdominal surgery

Related Conditions & MeSH terms

• Cholecystectomy, Laparoscopic

Intervention

Drug:
• Rocuronium (MB group)
Count of train-of-four: 1-2 Titration of rocuronium dose
• Rocuronium (DB group)
Post-tetanic count: 1-2 Titration of rocuronium dose

Locations

Country	Name	City	State
Korea, Republic of	Seoul National University Bundang Hospital	Seongnam	Gyeonggi

Sponsors (1)

Lead Sponsor	Collaborator
Seoul National University Bundang Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Total infused dose of propofol		At 1 min after the anesthesia is finished
Secondary	Electromyographic index presented on the anesthetic depth monitoring system		Through study completion, an average of 2 hours